NeuroFirst™ Memory Test
Rule-out of Alzheimer's Dementia in patients >60 with memory complaints
Ready to LaunchActive
Key Facts
Indication
Rule-out of Alzheimer's Dementia in patients >60 with memory complaints
Phase
Ready to Launch
Status
Active
Company
About Cx Precision Medicine
Cx Precision Medicine is a private, pre-revenue diagnostics company founded in 2019 and based in San Diego. Its core offering is the NeuroFirst™ platform, which uses proprietary algorithms to analyze blood protein biomarkers, aiming to rule out neurodegenerative disorders like Alzheimer's and Parkinson's at the primary care level. The company's technology is licensed from the research of Dr. Sid O'Bryant at the University of North Texas Health Science Center, positioning it to address critical gaps in early diagnosis and patient triage. CxPM is preparing to launch its first test while developing a pipeline of additional neurodegenerative diagnostic tools.
View full company profile